I hold and am glad to do so. In this modern era of 24x7 news it seems everyone is keen to breeze past the status quo, assume the cure is near at hand and invest in that future state.
I don't agree. Many of the articles I read these days talk about the status quo without rose tinted glasses and the consensus is 'testing, testing, testing'.
I don't believe CDY would be stupid enough to start selling a bad testing product into the market so, if and when they do announce their first round of sales and a follow on order for millions more dollars worth of that same test they are successfully selling, I'm going to read that as A) tests are good enough and B) since there's a huge demand for testing even in countries that are controlling C-19, that sales should be good for a while longer.
- Forums
- ASX - By Stock
- AN1
- Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received
Ann: Cellmid's Shipment of SARS-CoV-2 Tests Received, page-310
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online